PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPpv23
Ppv23
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
48 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pneumococcal infectionsD011008EFO_0000772J133245115
Human influenzaD007251EFO_0007328J11.1—1—7—8
Pneumococcal pneumoniaD011018EFO_1001474J131——5—6
PneumoniaD011014EFO_0003106J1831—2—5
Covid-19D000086382—U07.1———4—4
Streptococcus pneumoniaeD013296NCBITaxon_1313—1——2—3
VaccinationD014611EFO_0004292Z24———2—2
LeukemiaD007938—C95———2—2
Hiv infectionsD015658EFO_0000764B20—1—1—2
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.9———112
Show 27 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_0000544——11——2
Communicable diseasesD003141———11——2
Whooping coughD014917EFO_0000650A37111——2
TetanusD013742EFO_0005593A35111——2
DiphtheriaD004165EFO_0005549A36111——2
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Anti-neutrophil cytoplasmic antibody-associated vasculitisD056648—I77.82—1———1
Prostatic neoplasmsD011471—C61—1———1
Breast neoplasmsD001943EFO_0003869C50—1———1
Lung neoplasmsD008175—C34.90—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AgingD000375GO_0007568R41.812————2
LipodystrophyD008060—E88.11————1
Hiv-associated lipodystrophy syndromeD039682EFO_1001348—1————1
Kidney transplantationD016030——1————1
Respiratory tract infectionsD012141—J06.91————1
Respiratory tract diseasesD012140——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Retinal detachmentD012163EFO_0005773H33.2————11
Vision disordersD014786—H53.11————11
AniseikoniaD000839EFO_1001266H52.32————11
Dissociative disordersD004213—F44.1————11
ReinfectionD000084063——————11
Lung diseasesD008171EFO_0003818J98.4————11
HivD006678—O98.7————11
Immunologic deficiency syndromesD007153—D84.9————11
Primary immunodeficiency diseasesD000081207——————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use